These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17235514)

  • 1. PIK3CA alterations in primary (de novo) and secondary glioblastomas.
    Kita D; Yonekawa Y; Weller M; Ohgaki H
    Acta Neuropathol; 2007 Mar; 113(3):295-302. PubMed ID: 17235514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours.
    Izycka-Swieszewska E; Brzeskwiniewicz M; Wozniak A; Drozynska E; Grajkowska W; Perek D; Balcerska A; Klepacka T; Limon J
    Folia Neuropathol; 2010; 48(4):238-45. PubMed ID: 21225506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.
    Knobbe CB; Trampe-Kieslich A; Reifenberger G
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):486-90. PubMed ID: 16150119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers.
    Jacot W; Mollevi C; Fina F; Lopez-Crapez E; Martin PM; Colombo PE; Bibeau F; Romieu G; Lamy PJ
    BMC Cancer; 2015 Dec; 15():986. PubMed ID: 26680641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.
    Mizoguchi M; Nutt CL; Mohapatra G; Louis DN
    Brain Pathol; 2004 Oct; 14(4):372-7. PubMed ID: 15605984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.
    Mellinghoff IK; Wang MY; Vivanco I; Haas-Kogan DA; Zhu S; Dia EQ; Lu KV; Yoshimoto K; Huang JH; Chute DJ; Riggs BL; Horvath S; Liau LM; Cavenee WK; Rao PN; Beroukhim R; Peck TC; Lee JC; Sellers WR; Stokoe D; Prados M; Cloughesy TF; Sawyers CL; Mischel PS
    N Engl J Med; 2005 Nov; 353(19):2012-24. PubMed ID: 16282176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular changes in the phosphatidylinositide 3-kinase (PI3K) pathway are common in gastric cancer.
    Tran TN; Brettingham-Moore K; Duong CP; Mitchell C; Clemons NJ; Phillips WA
    J Surg Oncol; 2013 Aug; 108(2):113-20. PubMed ID: 23813545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.
    Knobbe CB; Reifenberger G
    Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.
    Endoh H; Yatabe Y; Kosaka T; Kuwano H; Mitsudomi T
    J Thorac Oncol; 2006 Sep; 1(7):629-34. PubMed ID: 17409929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status.
    Navarro L; Gil-Benso R; Megías J; Muñoz-Hidalgo L; San-Miguel T; Callaghan RC; González-Darder JM; López-Ginés C; Cerdá-Nicolás MJ
    Neuroscience; 2015 Jun; 297():243-51. PubMed ID: 25869624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic profile of the giant cell glioblastoma.
    Peraud A; Watanabe K; Schwechheimer K; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1999 Feb; 79(2):123-9. PubMed ID: 10068201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
    Griffith CC; Seethala RR; Luvison A; Miller M; Chiosea SI
    Am J Surg Pathol; 2013 Aug; 37(8):1201-7. PubMed ID: 23851329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
    Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
    Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic profile of gliosarcomas.
    Reis RM; Könü-Lebleblicioglu D; Lopes JM; Kleihues P; Ohgaki H
    Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.
    Wang MY; Lu KV; Zhu S; Dia EQ; Vivanco I; Shackleford GM; Cavenee WK; Mellinghoff IK; Cloughesy TF; Sawyers CL; Mischel PS
    Cancer Res; 2006 Aug; 66(16):7864-9. PubMed ID: 16912159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA mutations in glioblastoma multiforme.
    Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
    Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
    J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
    Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.